Go Pro
TSE:OGI

Organigram Q3 2026 Earnings Report

Organigram logo
C$1.59 +0.01 (+0.63%)
As of 09/4/2026 03:59 PM Eastern

Organigram EPS Results

Actual EPS
C$0.77
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
$105.78 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Organigram Earnings Headlines

Organigram surges 10% on record Q3 results
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the largest mineral reserve in the country - enough gold for a new Fort Knox, enough copper to rebuild the U.S. electric grid 25 times over. The Trump administration has previously staked positions in MP Materials, Lithium America, Trilogy Metals, and USA Rare Earth - each time shares moved higher. A landmark policy decision expected before November 3 could reprice this stock from $2 to $20 or more within a year.tc pixel
Organigram global Q3 earnings preview
Organigram Global Inc OGI
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

View Organigram Profile